How Balo's Concentric Sclerosis is Diagnosed
At a Glance
Balo's concentric sclerosis is usually assessed with MRI showing alternating rings in brain white matter, plus blood and spinal-fluid tests to exclude similar disorders. A brain biopsy may still be needed when scans are atypical or cancer and infection remain possible.
Because Balo’s Concentric Sclerosis (BCS) can look like a brain tumor or a stroke on an initial scan, the diagnostic process is focused on confirming the unique “onion-skin” pattern and ruling out other conditions. In the past, a brain biopsy was almost always required to confirm BCS, but today, doctors rely heavily on advanced imaging and specialized lab tests [1][2].
The Hallmark: MRI Findings
The most critical tool for diagnosing BCS is the Magnetic Resonance Imaging (MRI). Your radiologist and neurologist will look for a very specific type of lesion—a round or oval area of inflammation in the white matter of the brain [1].
- The Concentric Pattern: On T2-weighted or FLAIR MRI sequences (scans that highlight water and inflammation in the brain), BCS shows alternating rings of light and dark. This represents layers where myelin has been lost (demyelination) next to layers where it has been preserved [3][4].
- Contrast Enhancement: When a contrast dye (gadolinium) is used during the MRI, it often highlights the outermost ring or shows a “bullseye” pattern. This indicates a disruption of the blood-brain barrier, helping your doctor see where active inflammation is currently happening [1][5].
- “Mass Effect”: Because BCS lesions can be large, they may push on surrounding brain tissue, causing swelling (edema) that can be mistaken for a tumor [6][7]. It is important to know that a ring pattern alone does not definitively confirm BCS; the entire clinical picture must be reviewed.
Assessing the Need for a Brain Biopsy
One of the most important multidisciplinary discussions you will have with your neurologist is whether a brain biopsy (surgically removing a small piece of brain tissue) is necessary. There are no universally accepted diagnostic criteria for BCS, but current medical consensus suggests that a biopsy can sometimes be avoided if three factors are present:
- Classic Imaging: The MRI shows the clear, unmistakable concentric ring pattern [6][7].
- Acute Presentation: Your symptoms came on suddenly and fit the location of the lesion [6].
- Steroid Response: Your symptoms and the MRI findings improve significantly after treatment with high-dose corticosteroids [7][8].
However, improving on steroids does not definitively prove you have BCS. Primary CNS lymphoma and some tumors can temporarily improve with steroids, which can also mask the cancer on a subsequent biopsy. A biopsy or further evaluation may still be required when imaging is atypical, you have a history of immunosuppression, your symptoms worsen, or cancer/infection has not been adequately excluded [9][10].
Essential Lab Tests and “Mimics”
Because BCS is so rare, your care team must rule out other “mimics.” This typically requires both blood work and a lumbar puncture (spinal tap), though testing is individualized for every patient.
Differentiating BCS from Other Disorders
Your doctors may test your blood and spinal fluid for specific markers to see if your condition is actually a different demyelinating disease:
- AQP4 and MOG Antibodies: These tests help evaluate for Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG-Antibody-Associated Disease (MOGAD). While these tests are often negative in classic BCS, a negative result does not completely exclude NMOSD or MOGAD, as assay choice, timing, and seronegative disease matter [6][1].
- Oligoclonal Bands (OCBs): These are proteins often found in the spinal fluid of people with Multiple Sclerosis (MS). Interestingly, while 95% of MS patients have these bands, some studies show they can be absent in about 66% of BCS patients [11]. These tests help evaluate alternative diagnoses but do not independently confirm or exclude BCS.
Ruling Out Other Conditions
BCS can look remarkably similar to several other conditions on an MRI:
- Tumors and Lymphoma: High-grade brain tumors or Primary CNS Lymphoma can mimic the appearance of a BCS lesion and may temporarily improve with high-dose corticosteroids [9][8].
- Tumefactive Demyelination: This is a spectrum of MS lesions that are very large (over 2cm) and can look like a mass. BCS is commonly considered within this tumefactive spectrum, and the imaging can overlap [12][13].
- Infections: In rare cases, certain infections like a brain abscess or tuberculosis can create ring-like patterns on an MRI [10][14].
If your imaging is classic and your lab tests for other antibodies are negative, your neurologist can be much more confident in a presumptive diagnosis of Balo’s Concentric Sclerosis, but close follow-up remains vital [6][1].
Common questions in this guide
What does the MRI look like in Balo's concentric sclerosis?
Can a good steroid response confirm Balo's concentric sclerosis?
Which blood and spinal-fluid tests help distinguish BCS from other demyelinating diseases?
Why might doctors recommend a brain biopsy for BCS?
How is Balo's concentric sclerosis monitored after an initial diagnosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Do my MRI scans show the 'classic' concentric rings or are the findings more atypical?
- 2.Since I responded well to steroids, do you think we can safely avoid a brain biopsy at this time?
- 3.Were my AQP4 and MOG antibody tests negative, and what does that tell us about my prognosis?
- 4.Does my spinal fluid show oligoclonal bands, and how does that affect my diagnosis of BCS versus typical Multiple Sclerosis?
- 5.What is our plan for a follow-up MRI to ensure the lesions are shrinking or stable?
- 6.If we were to consider a biopsy, what specific information would we be looking for that we don't have yet?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Clinical and Radiologic Features, Pathology, and Treatment of Baló Concentric Sclerosis.
Jolliffe EA, Guo Y, Hardy TA, et al.
Neurology 2021; (97(4)):e414-e422 doi:10.1212/WNL.0000000000012230.
PMID: 34011576 - 2
Baló's concentric sclerosis - A rare entity within the spectrum of demyelinating diseases.
Xie JS, Jeeva-Patel T, Margolin E
Journal of the neurological sciences 2021; (428()):117570 doi:10.1016/j.jns.2021.117570.
PMID: 34261000 - 3
A Rare Case of Balo Concentric Sclerosis, a Subtype of Tumefactive Multiple Sclerosis, in a 40-Year-Old Male: Case Report.
Al Ashi AK, Meray V, Aziz AM
Cureus 2022; (14(4)):e24033 doi:10.7759/cureus.24033.
PMID: 35547427 - 4
7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions.
Behrens JR, Wanner J, Kuchling J, et al.
Annals of clinical and translational neurology 2018; (5(8)):900-912 doi:10.1002/acn3.572.
PMID: 30128315 - 5
Peripheral late reactivation of a previously typical monofocal Baló's concentric sclerosis lesion.
Pique J, Bonneville F, Brassat D, et al.
Multiple sclerosis (Houndmills, Basingstoke, England) 2015; (21(8)):1080-3 doi:10.1177/1352458515586087.
PMID: 26014609 - 6
Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome.
Hardy TA
Current opinion in neurology 2019; (32(3)):467-474 doi:10.1097/WCO.0000000000000683.
PMID: 30844860 - 7
Why Is This Auntminnie a Diagnostic Conundrum?: A Knowledge-Based Approach to Balo's Concentric Sclerosis From Reports of 3 Cases and Pooled Data From 68 Other Patients in the Literature.
Agarwal M, Ulmer JL, Klein AP, Mark LP
Current problems in diagnostic radiology 2019; (48(4)):415-422 doi:10.1067/j.cpradiol.2017.12.008.
PMID: 29428181 - 8
Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant.
Moineau-Vallée K, Rinfret J, Luu Hoai MH, et al.
Current oncology (Toronto, Ont.) 2020; (28(1)):203-208 doi:10.3390/curroncol28010022.
PMID: 33704187 - 9
Case Report: Post-transplant lymphoproliferative disorder mimicking Baló's concentric sclerosis.
Xiong X, Zhang T, Li Y, et al.
Frontiers in oncology 2026; (16()):1819442 doi:10.3389/fonc.2026.1819442.
PMID: 42339124 - 10
Balo's Concentric Sclerosis Mimicking Cerebral Tuberculoma.
Son YR, Yang H, Lee S, et al.
Experimental neurobiology 2015; (24(2)):169-72 doi:10.5607/en.2015.24.2.169.
PMID: 26113796 - 11
Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.
Jarius S, Würthwein C, Behrens JR, et al.
Journal of neuroinflammation 2018; (15(1)):22 doi:10.1186/s12974-017-1043-y.
PMID: 29347989 - 12
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
Frederick MC, Cameron MH
Current neurology and neuroscience reports 2016; (16(3)):26 doi:10.1007/s11910-016-0626-9.
PMID: 26847090 - 13
Advanced quantitative MRI reveals a unique pattern of metabolic alterations and iron-pathology linked to glial activation in Baló's concentric sclerosis.
Dempegioti CA, Broumpoulis G, Brinia ME, et al.
Journal of neuroimmunology 2026; (410()):578798 doi:10.1016/j.jneuroim.2025.578798.
PMID: 41207107 - 14
Bilateral optic neuritis preceding a Baló concentric sclerosis lesion: A case report and literature review.
Alfonso-Cedeño DF, Medina-Lozano L, Gaete PV, Quintero-Cusguen P
Journal of neuroimmunology 2026; (413()):578874 doi:10.1016/j.jneuroim.2026.578874.
PMID: 41619449
This page is for informational purposes only and does not constitute medical advice. Your neurologist and radiologist should interpret your MRI, laboratory results, and need for biopsy in the context of your care.
Get notified when new evidence is published on Baló concentric sclerosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.